Competitor to Amgen’s Epogen also moves closer to market
Results give advantage to Boehringer/Lilly’s Jardiance.
App also achieves 98% sensitivity and 90.2% specificity.
Confirm Rx Insertable Cardiac Monitor transmits data to smartphone app.
Could this be the end of the road for serelaxin?
AZ hopes data will boost sales of its Farxiga.
Repatha cuts cardio events, but not mortality.